Skip to main content
. 2020 Jun 8;12(6):524. doi: 10.3390/pharmaceutics12060524

Figure 3.

Figure 3

Schematic representation of the mechanism of the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) pathway. PI3K—phosphatidylinositol 3-kinase, PIP—phosphatidylinositol–3,4,5-trisphosphate, PTEN—phosphatase and tensin homolog, PDK—phosphoinositide-dependent protein kinase, AKT—a serine/threonine-specific protein kinase, TSC—tuberous sclerosis protein, Rheb—Ras homolog enriched in brain, MTORC1—mammalian target of rapamycin complex-1, RAF—an acronym for rapidly accelerated fibrosarcoma, MEK—mitogen-activated protein kinase.